CD4 and myeloid sarcoma: It has been proven by both experimental autoimmune encephalomyelitis (EAE) model and MS treatment studies that CD4+ T cells that migrate to the CNS are activated by antigen-presenting cells and direct leukocytes such as T and B cells and macrophages to initiate myelin damage [33, 34].